Protective Proteolysis in Huntington's Disease: Unraveling the Role of Post-Translational Myristoylation of Huntingtin in Autophagy

被引:0
|
作者
Alshehabi, Yasmeen [1 ]
Martin, Dale D. O. [1 ]
机构
[1] Univ Waterloo, Fac Sci, Dept Biol, NeurdyPhagy Lab, Waterloo, ON, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Autophagy; huntingtin; myristoylation; neurodegeneration; proteolysis; N-TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; CASPASE CLEAVAGE; TRINUCLEOTIDE REPEAT; BINDING PROTEIN; MOUSE MODEL; CAG REPEAT; TOXICITY; MINOCYCLINE; ACTIVATION;
D O I
10.3233/JHD-240028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a devastating neurodegenerative disorder characterized by impaired motor function and cognitive decline, ultimately leading to death. HD is caused by a polyglutamine expansion in the N-terminal region of the huntingtin (HTT) protein, which is linked to decreased HTT turnover, increased HTT proteolysis, increased HTT aggregation, and subsequent neuronal death. In this review, we explore the mechanism of the protective effect of blocking HTT proteolysis at D586, which has been shown to rescue the HD phenotype in HD mouse models. Until recently, the mechanism remained unclear. Herein, we discuss how blocking HTT proteolysis at D586 promotes HTT turnover by correcting autophagy, and making HTT a better autophagy substrate, through post-translational myristoylation of HTT at G553.
引用
收藏
页码:267 / 277
页数:11
相关论文
共 50 条
  • [21] The Involvement of Post-Translational Modifications in Alzheimer's Disease
    Marcelli, Serena
    Corbo, Massimo
    Iannuzzi, Filomena
    Negri, Lucia
    Blandini, Fabio
    Nistico, Robert
    Feligioni, Marco
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (04) : 313 - 335
  • [22] Post-translational modification of α-synuclein in Parkinson's disease
    Barrett, Paul J.
    Greenamyre, J. Timothy
    BRAIN RESEARCH, 2015, 1628 : 247 - 253
  • [23] Huntingtin, the Major Factor in Huntington's Disease Development. Main Functions and Intracellular Proteolysis
    Gotmanova, N. N.
    Bacheva, A. V.
    MOSCOW UNIVERSITY CHEMISTRY BULLETIN, 2024, 79 (03) : 189 - 194
  • [24] The role of post-translational modifications in acute and chronic cardiovascular disease
    Smith, Lauren E.
    White, Melanie Y.
    PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (7-8) : 506 - 521
  • [25] Revealing the role of epigenetic and post-translational modulations of autophagy proteins in the regulation of autophagy and cancer: a therapeutic approach
    Chowdhury, Sougata Ghosh
    Karmakar, Parimal
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [26] Huntingtin oligomeric structures and their potential neurotoxic role in Huntington's disease
    Porat, Y.
    Hou, Z.
    Ross, C. A.
    Poirier, M.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2006, 2 (04) : 317 - 317
  • [27] The role of post-translational modifications of cGAS in γS T cells
    Liu, Yanyan
    Huang, Yue
    Wei, Haotian
    Liang, Xinjun
    Luo, Jing
    MOLECULAR IMMUNOLOGY, 2024, 175 : 146 - 154
  • [28] Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models
    Sontag, Emily Mitchell
    Lotz, Gregor P.
    Agrawal, Namita
    Tran, Andrew
    Aron, Rebecca
    Yang, Guocheng
    Necula, Mihaela
    Lau, Alice
    Finkbeiner, Steven
    Glabe, Charles
    Marsh, J. Lawrence
    Muchowski, Paul J.
    Thompson, Leslie M.
    JOURNAL OF NEUROSCIENCE, 2012, 32 (32): : 11109 - 11119
  • [29] Post-translational modification and mitochondrial function in Parkinson's disease
    Luo, Shishi
    Wang, Danling
    Zhang, Zhuohua
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 16
  • [30] Targeting α-synuclein post-translational modifications in Parkinson's disease
    Canever, Jaquelini B.
    Soares, Ericks Sousa
    de Avelar, Nubia C. P.
    Cimarosti, Helena I.
    BEHAVIOURAL BRAIN RESEARCH, 2023, 439